Clinical studies recruiting near Garran

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · ACT Pain Centre · Saluda Medical Pty Ltd · NCT04662905 Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · Canberra Hospital · Monash University · NCT05678621 ROADMAP Clinical Trial
Phase 4 · The Canberra Hospital · University of Newcastle, Australia · NCT06771050 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · The Canberra Hospital · Takeda · NCT06499285 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Phase 2 · Canberra Hospital · Canadian Cancer Trials Group · NCT05640999 A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Phase N/A · Canberra Hospital · Swedish Orphan Biovitrum · NCT05776472 The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Phase 3 · The Canberra Hospital · The George Institute · NCT06058585 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · Canberra Hospital /ID# 277166 · AbbVie · NCT07155187 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · The Canberra Hospital · Nordic Lymphoma Group · NCT04332822 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Canberra Hospital · University of Leicester · NCT04204915 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · The Canberra Hospital (TCH) - Canberra Region Cancer Centre · Bayer · NCT06452277 MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · The Canberra Hospital · Intellia Therapeutics · NCT06128629 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Canberra Hospital · Mirati Therapeutics Inc. · NCT04613596 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Canberra Hospital · Amgen · NCT07136012 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · Canberra Hospital · Boehringer Ingelheim · NCT06872892 A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus
Phase 2/Phase 3 · Local Institution - 0368 · Bristol-Myers Squibb · NCT07063745 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Pr
Phase 3 · Canberra Hospital · Boehringer Ingelheim · NCT06238622 A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Phase 3 · Research Site · AstraZeneca · NCT06549595 A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment
NA · Canberra Heart Rhythm · Biosense Webster, Inc. · NCT06455098 AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Can
Phase 3 · Research Site · AstraZeneca · NCT07218809 A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Phase 3 · The Canberra Hospital · Incyte Corporation · NCT07623200 A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
Phase 2 · Canberra Hospital · Australasian Gastro-Intestinal Trials Group · NCT06290505 A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participan
Phase 3 · The Canberra Hospital · Hoffmann-La Roche · NCT06819878 Staphylococcus Aureus Network Adaptive Platform Trial
Phase 4 · Canberra Hospital · University of Melbourne · NCT05137119 A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatini
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07218926 A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilz
Phase 1/Phase 2 · Canberra Hospital · BeOne Medicines · NCT04973605 A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Phase 3 · Canberra Hospital · Takeda · NCT06722235 A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Ye
Phase 2 · Investigational Site Number : 0360003 · Sanofi · NCT06500702

Look up another city

Look up another condition